Literature DB >> 15245740

Immune control of herpes simplex virus during latency.

Kamal M Khanna1, Andrew J Lepisto, Vilma Decman, Robert L Hendricks.   

Abstract

Herpes simplex virus type 1 (HSV-1) persists within the host in the presence of concomitant immunity by establishing a latent infection within sensory neurons. HSV-1 latency is widely viewed as a neuron-enforced quiescent state of the virus, in which a lack of viral protein synthesis prevents recognition of the infected neuron by the host immune system. On the basis of recent findings, however, we propose a more dynamic view of HSV-1 latency characterized by persistent or intermittent low-level viral gene expression in some latently infected neurons. We further propose that HSV-1-specific memory/effector CD8(+) T lymphocytes that are retained in the ganglion in close apposition to the neurons prevent full reactivation and virion formation through IFN-gamma production and an additional undefined mechanism(s).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15245740     DOI: 10.1016/j.coi.2004.05.003

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  54 in total

1.  Quantitative analysis of herpes simplex virus type 1-specific memory B cells generated by different routes of infection.

Authors:  Daisy J Vanitha; Hye Mee Joo; Barry T Rouse; Mark Y Sangster
Journal:  Virology       Date:  2006-11-17       Impact factor: 3.616

2.  Immunological thresholds in neurological gene therapy: highly efficient elimination of transduced cells might be related to the specific formation of immunological synapses between T cells and virus-infected brain cells.

Authors:  Carlos Barcia; Christian Gerdes; Wei-Dong Xiong; Clare E Thomas; Chunyan Liu; Kurt M Kroeger; Maria G Castro; Pedro R Lowenstein
Journal:  Neuron Glia Biol       Date:  2006-11

Review 3.  How does spaceflight affect the acquired immune system?

Authors:  Taishin Akiyama; Kenta Horie; Eiichi Hinoi; Manami Hiraiwa; Akihisa Kato; Yoichi Maekawa; Akihisa Takahashi; Satoshi Furukawa
Journal:  NPJ Microgravity       Date:  2020-05-07       Impact factor: 4.415

Review 4.  Making the case: married versus separate models of alphaherpes virus anterograde transport in axons.

Authors:  R Kratchmarov; M P Taylor; L W Enquist
Journal:  Rev Med Virol       Date:  2012-07-16       Impact factor: 6.989

5.  Association of Depressed Mood With Herpes Simplex Virus-2 Immunoglobulin-G Levels in Pregnancy.

Authors:  Pao-Chu Hsu; Robert H Yolken; Teodor T Postolache; Theresa M Beckie; Cindy L Munro; Maureen W Groer
Journal:  Psychosom Med       Date:  2016-10       Impact factor: 4.312

6.  Comparison of inflammatory infiltrates in trigeminal ganglia of cattle infected with wild-type Bovine herpesvirus 1 versus a virus strain containing a mutation in the LR (latency-related) gene.

Authors:  Sandra Perez; Luciane Lovato; Joe Zhou; Alan Doster; Clinton Jones
Journal:  J Neurovirol       Date:  2006-10       Impact factor: 2.643

7.  Chronic cortical and subcortical pathology with associated neurological deficits ensuing experimental herpes encephalitis.

Authors:  Anibal G Armien; Shuxian Hu; Morgan R Little; Nicholas Robinson; James R Lokensgard; Walter C Low; Maxim C-J Cheeran
Journal:  Brain Pathol       Date:  2009-11-05       Impact factor: 6.508

8.  Effector CD4+ T-cell involvement in clearance of infectious herpes simplex virus type 1 from sensory ganglia and spinal cords.

Authors:  Alison J Johnson; Chin-Fun Chu; Gregg N Milligan
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

9.  [Acute retinal necrosis from the virologist's perspective].

Authors:  P Rautenberg; L Grancicova; J Hillenkamp; B Nölle; J B Roider; H Fickenscher
Journal:  Ophthalmologe       Date:  2009-12       Impact factor: 1.059

10.  Herpesvirus Infections and Risk of Frailty and Mortality in Older Women: Women's Health and Aging Studies.

Authors:  George C Wang; Christina Han; Barbara Detrick; Vincenzo Casolaro; David M Levine; Linda P Fried; Jeremy D Walston
Journal:  J Am Geriatr Soc       Date:  2016-04-30       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.